Finoriq research workspace
Revolution Medicines, Inc. (RVMD) Insider Transactions & Form 4 Activity
Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Revolution Medicines, Inc. (RVMD).
Company Snapshot
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
- Company
- Revolution Medicines, Inc. (RVMD)
- Ticker
- RVMD
- Market Cap
- $38.7B
- Latest Price
- $181.88
- Industry
- Biotech & Pharma
Revolution Medicines, Inc. (RVMD) Recent Insider Transactions
Recent market insider transaction records indexed for Revolution Medicines, Inc. (RVMD).
| Insider | Code | Value | Transaction Date |
|---|---|---|---|
| GOLDSMITH MARK ASee Remarks | S | Disposed | -$18M | 2026-04-15 |
| Mancini AnthonySee Remarks | S | Disposed | -$167,801 | 2026-03-25 |
| Mancini AnthonySee Remarks | S | Disposed | -$294,520 | 2026-03-25 |
| Mancini AnthonySee Remarks | S | Disposed | -$2M | 2026-03-25 |
| Mancini AnthonySee Remarks | S | Disposed | -$1.1M | 2026-03-25 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.